Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee

December 15, 2005

Briefing Information

ZOSTAVAX™ - Varicella Virus Vaccine Live (Oka/Merck)

FDA Clinical Briefing Document, Patricia Rohan, MD (HTM) (PDF)

FDA Statistical Review and Evaluation, Sang Ahnn, PhD (HTM) (PDF)

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

ZOSTAVAX™ - Varicella Virus Vaccine Live (Oka/Merck), Merck Research Laboratories (PDF)